Medicare Access & CHIP Reauthorization Act of 2015

Contact us
MACRA

MACRA

Beginning in 2019, Medicare payments through MACRA are to begin the phasing out of traditional fee-for-service payments.

The law repealed the annual Sustainable Growth Rate (SGR) formula, linking Medicare annual payment updates to prior year spending and gross domestic product (GDP) growth.

The law mandates that Medicare payment increases remain stable at 0.5 percent through 2019, and then remain flat through 2025. The first performance assessment year toward MACRA scoring is 2017, based on existing models providers are utilizing to determine payment in 2019, after which the new reporting structures begin.

The new Medicare payment models begin offering eligible clinicians (ECs) two payment tracks within the transition to value-based care and population health management; the Merit-based Incentive Payment System (MIPS) and the Alternative Payment Models (APM) tracks.

Merit-based Incentive Payment System (MIPS)

Overall, MIPS has four scoring pillars from which providers will be assessed a 100-point scoring scale. The pillars are comprised of:

  • Quality – Replaces PQRS and the value-based modifier quality, requires reporting of six measures
  • Advancing Care Information – Formerly MU with similar but decreased measures focusing on data exchange
  • Cost – Originally referred to as Resource Use, this scoring is based on Medicare claims and requires no reporting
  • Improvement Activities – Expanded list of 90 options from nine categories. Basic APM and PCMH participation included in scoring options

Based on total scores, EPs will either be assessed an up or down payment adjustment ranging from four to nine percent annually from 2019 to 2022 and beyond, capping at nine percent.

MIPS ECs

Medicare Part B providers subject to MIPS include:

  • Physicians
  • Physician Assistants
  • Nurse Practitioners
  • Certified RN Anesthetists
  • Clinical Nurse Specialists

From 2021 onward, the law allows for additional EP types to be added.

Alternative Payment Models (APMs)

The APM track offers extra incentive rewards for providers in a variety of ACO, medical home and related value-based care payment models.

This model rewards two tiers of APM participation. Advanced APM participation – based on risk, include a 5 percent lump-sum bonus from 2019 to 2024 and higher fee schedule updates are offered. Providers in the Advanced APM track are also excluded from the MIPS track requirements.

Other more basic APM model participation – such as bundled payment programs – offers scoring preference in the MIPS Clinical Practice Improvement pillar.

Advanced APM participation, though, is based on qualifying within certain revenue and patient volume, as well as risk, factors: 

  • In 2019 and 2020, qualifying providers are to have 25% of payments or patients in an APM to qualify for the track and its incentives
  • In 2021 and 2022, 50% of payments or patients within an APM, or through a combination of APMs and other payment arrangements
  • Beginning in 2023, 75% APM or the combination of an APM and other payments
Checklist

MACRA Overview and Checklist:

This MACRA checklist prepares your organization for value-based care and helps determine which pathway you are best aligned with.

View checklist »

Philips Wellcentive advocates for providers and healthcare stakeholders on matters of public policy through public comment letters and interaction with government entities.


Philips Wellcentive is an ONC-ACB 2014 Edition certified technology.

View Certification Disclosure

Leslie Botnick, M.D
We determined as an organization that reporting on oncology measures alone would do little to improve the care we deliver our patients. We serve our patients best when we remain ahead of government requirements for quality. By focusing on preventive measures—which have real relevance to cancer outcomes—our clinicians consider the whole patient, not just a portion of their care and not just the disease.”

Leslie Botnick, M.D., Co-Founder and CMO, Vantage Oncology

We determined as an organization that reporting on oncology measures alone would do little to improve the care we deliver our patients. We serve our patients best when we remain ahead of government requirements for quality. By focusing on preventive measures—which have real relevance to cancer outcomes—our clinicians consider the whole patient, not just a portion of their care and not just the disease.”

Leslie Botnick, M.D., Co-Founder and CMO, Vantage Oncology

Key capabilities

Aggregation

Aggregation

Aggregate and normalize data from multiple clinical and claims systems

Analytics

Analytics

Provide actionable insight for any PHM or VBR program

Action

Action

Proactively improve clinical outcomes and optimize utilization

Accountability

Accountability

Submit data and outcomes directly to CMS and Commercial Payers

 

Disrupting care delivery for the better

Cindy Gaines, Vice President and Chief Operating Officer of Borgess Health, a member of Ascension Health, breaks down how population health has disrupted their care delivery model for the better—and how Philips Wellcentive’s PHM solutions are helping them meet their accountability measures and enhance their patient engagement strategies.

Let’s talk   

What are your biggest challenges in value-based care? Every day, we are helping providers transform the way they deliver care, supporting enhanced patient outcomes and improved use of data. Reach out to us today to learn how you can avoid the cost of inaction and power your success in the new healthcare landscape.

Contact us today to start your journey to value-based care success.